Market Chatter: Maeil Dairies to Supply Specialized Infant Formula to China via Alibaba Health

MT Newswires Live08-30

Maeil Dairies (KOSDAQ:267980) will expand its supply of specialized infant formula for congenital metabolic disorders to China via Alibaba Health (HKG:0241), Pulse News reported Thursday.

The South Korean infant formula maker will offer 12 products across eight categories in the Chinese market. This expansion follows a charity partnership with Alibaba Health that was signed in May, the report said.

Maeil Dairies will also host an exchange meeting in September to discuss congenital metabolic disorders with healthcare professionals and families from South Korea and China, it said.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment